Abstract: Background:Hyperlipidaemia is a significant
risk factor for all ischemic heart disorders and Hypertension, many research
studies linked the majority of cases to obesity, there is across link between
obesity and Hyperlipidaemia, so the lipid profile
post-operative was examined in the most common bariatric surgeries. The purpose
of this work was to conduct a comparison of laparoscopic gastric bypass and laparoscopic
sleeve gastrectomy (LSG) for managing of Hyperlipidemia and related complications.
Methods:This prospective work had been carried out on 52 individuals
aging between 18 and 65 years old of both genders, BMI of 30-45 kg/m2,
A reported history of unsuccessful weight reduction efforts in the past,
coupled with strong desire for surgical intervention. The study participants
were categorized into two distinct groups: group I (n=26) consisted of individuals with obesity who received LSG, whereas group II (n=26) included individuals with obesity who received Laparoscopic
Gastric bypass.
Results: The mean cholesterol
levels following a period of 3 months were found to be 156.92±14.90 and
163.08±16.31 for the bypass and LSG groups, correspondingly. No statistically
significant variation was seen among the bypass and LSG. The cholesterol levels
following 3 months were favorable in all subjects who had bypass surgery, with
96.15% achieving a good outcome in LSG, and 3.85% experiencing a non-desirable
outcome in LSG. The average triglyceride levels following a period of 3 months
were found to be 129.23±13.47 and 144.62±14.21 for the bypass and LSG groups,
correspondingly. A notable disparity was seen among the bypass and LSG. The
Triglyceride levels seen following a 3-month period were found to be
favorable in 92.31% of bypass cases and 57.69% of LSG cases, whereas they were
deemed unfavorable in 7.69% of bypass cases and 42.31% of LSG cases among bypass
and LSG. A statistically significant disparity was seen among the bypass
surgery and the LSG procedure.
Conclusions: Gastric bypass was correlated with better outcomes contrasted to SG in control
of hyperlipidemia in obese individuals. This is revealed in more loss following
1-year, better serum cholesterol and triglycerides following 3, 6 months, and 1
year.